DK0747389T3 - 3'-substituerede nukleosidderivater - Google Patents

3'-substituerede nukleosidderivater

Info

Publication number
DK0747389T3
DK0747389T3 DK95940427T DK95940427T DK0747389T3 DK 0747389 T3 DK0747389 T3 DK 0747389T3 DK 95940427 T DK95940427 T DK 95940427T DK 95940427 T DK95940427 T DK 95940427T DK 0747389 T3 DK0747389 T3 DK 0747389T3
Authority
DK
Denmark
Prior art keywords
group
substituted nucleoside
substituted
chem
ester
Prior art date
Application number
DK95940427T
Other languages
Danish (da)
English (en)
Inventor
Akira Matsuda
Takuma Sasaki
Original Assignee
Taiho Pharmaceutical Co Ltd
Akira Matsuda
Takuma Sasaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd, Akira Matsuda, Takuma Sasaki filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0747389T3 publication Critical patent/DK0747389T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95940427T 1994-12-13 1995-12-13 3'-substituerede nukleosidderivater DK0747389T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30891294 1994-12-13
JP20864595 1995-08-16
PCT/JP1995/002554 WO1996018636A1 (fr) 1994-12-13 1995-12-13 Derives de nucleoside substitues en 3'

Publications (1)

Publication Number Publication Date
DK0747389T3 true DK0747389T3 (da) 2004-01-26

Family

ID=26516961

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95940427T DK0747389T3 (da) 1994-12-13 1995-12-13 3'-substituerede nukleosidderivater

Country Status (18)

Country Link
US (2) US5763418A (de)
EP (1) EP0747389B1 (de)
JP (1) JP3142874B2 (de)
KR (1) KR0177372B1 (de)
CN (1) CN1195768C (de)
AT (1) ATE249471T1 (de)
AU (1) AU674639B2 (de)
CA (1) CA2182707C (de)
DE (1) DE69531729T2 (de)
DK (1) DK0747389T3 (de)
ES (1) ES2206522T3 (de)
FI (1) FI118967B (de)
HU (1) HU217772B (de)
NO (1) NO305702B1 (de)
NZ (1) NZ297100A (de)
PT (1) PT747389E (de)
RU (1) RU2130029C1 (de)
WO (1) WO1996018636A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763418A (en) * 1994-12-13 1998-06-09 Akira Matsuda 3'-substituted nucleoside derivatives
CA2172471C (en) * 1995-03-29 1999-01-26 Hua Qi Apparatus for and method of simulating ocular optical system
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
KR20030036189A (ko) * 2000-05-26 2003-05-09 이데닉스(케이만)리미티드 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물
WO2003026589A2 (en) 2001-09-28 2003-04-03 Idenix (Cayman) Limited Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
AU2003248748A1 (en) * 2002-06-28 2004-01-19 Idenix (Cayman) Limited 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) * 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
RS114104A (en) * 2002-06-28 2007-02-05 Idenix (Cayman) Limited, 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
KR20050088079A (ko) 2002-11-15 2005-09-01 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
EP2319853B1 (de) * 2002-12-12 2014-03-12 IDENIX Pharmaceuticals, Inc. Verfahren zur Herstellung von 2 -verzweigten Nucleosiden
WO2005011709A1 (en) * 2003-02-19 2005-02-10 Yale University Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections
BRPI0512360A (pt) * 2004-06-23 2008-03-11 Idenix Cayman Ltd derivados de 5-aza-7-deazapurina para o tratamento de flaviviridae
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
US7781576B2 (en) * 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
MX2009001003A (es) * 2006-07-24 2009-02-06 Taiho Pharmaceutical Co Ltd Derivado de 3'-etinilcitidina.
JP5066737B2 (ja) 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
JP4954004B2 (ja) 2007-08-09 2012-06-13 株式会社バイオダイナミクス研究所 任意の化合物が導入された新規核酸誘導体、及びその製造方法
CA2719202A1 (en) * 2008-03-27 2009-10-01 Taiho Pharmaceutical Co., Ltd. Anti-tumor agent comprising cytidine derivative and carboplatin
US9556216B2 (en) 2012-08-31 2017-01-31 Novartis Ag 2′-Ethynyl nucleoside derivatives for treatment of viral infections
NZ754171A (en) * 2016-12-22 2022-12-23 Calithera Biosciences Inc Ectonucleotidase inhibitors and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3480613A (en) * 1967-07-03 1969-11-25 Merck & Co Inc 2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
DE1950038A1 (de) * 1968-10-04 1970-04-09 Esco Corp Abdeckelement fuer die Kanten von Baggerschaufeln od.dgl.
DE3924424A1 (de) * 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
DE4204032A1 (de) * 1992-02-12 1993-08-19 Boehringer Mannheim Gmbh Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
EP0598910A1 (de) * 1992-03-11 1994-06-01 Japan Tobacco Inc. Verfahren zur herstellung von nukleosidderivaten
DE4418690A1 (de) * 1994-05-28 1996-01-11 Boehringer Mannheim Gmbh Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
US5681940A (en) * 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
US5763418A (en) * 1994-12-13 1998-06-09 Akira Matsuda 3'-substituted nucleoside derivatives

Also Published As

Publication number Publication date
CN1195768C (zh) 2005-04-06
HU9602214D0 (en) 1996-11-28
NO963350L (no) 1996-10-11
HUT75227A (en) 1997-04-28
JP3142874B2 (ja) 2001-03-07
AU674639B2 (en) 1997-01-02
EP0747389A1 (de) 1996-12-11
FI118967B (fi) 2008-05-30
DE69531729T2 (de) 2004-08-05
FI963148A0 (fi) 1996-08-12
DE69531729D1 (de) 2003-10-16
USRE38090E1 (en) 2003-04-22
WO1996018636A1 (fr) 1996-06-20
FI963148A (fi) 1996-08-12
NO305702B1 (no) 1999-07-12
RU2130029C1 (ru) 1999-05-10
NZ297100A (en) 1997-10-24
AU4188496A (en) 1996-07-03
US5763418A (en) 1998-06-09
ES2206522T3 (es) 2004-05-16
PT747389E (pt) 2003-12-31
KR0177372B1 (ko) 1999-04-01
NO963350D0 (no) 1996-08-12
EP0747389A4 (de) 1998-12-30
EP0747389B1 (de) 2003-09-10
CA2182707C (en) 2000-05-30
HU217772B (hu) 2000-04-28
KR970701198A (ko) 1997-03-17
ATE249471T1 (de) 2003-09-15
CN1140453A (zh) 1997-01-15

Similar Documents

Publication Publication Date Title
ATE249471T1 (de) 3'-substuierte nukleosidderivate
DK0536936T3 (da) Pyrimidinnukleosidderivater med anti-tumor-aktivitet, deres fremstilling og anvendelse
DK535789D0 (da) Pyrimidindionderivater, fremgangsmaade til fremstilling heraf og antiarytmika omfattende samme
ES2118069T3 (es) Profarmacos de fosfonatos.
DE69814375D1 (de) Fungizide trifluoromethylalkylamino-triazolopyrimidine-derivate
HK1041828A1 (en) Use of cytidine derivatives for the treatment of leukaemia
NL300247I2 (nl) 2-Halogeen-9-(2-desoxy-2-fluor-bêta-D-arabinofuranosyl)-adeninenucleosiderivaten.
DE69025529D1 (de) Weitere antivirale Pyrimidin-Nukleosiden
DE69109482D1 (en) Pyrimidinnucleosidderivat.
YU47802A (sh) Postupci i kompozicije za levovirin
ATE86866T1 (de) Antikrebs-zusammensetzung.
PT92080A (pt) Processo para a preparacao de novos glicosidos antraciclinicos e de antraciclinonas 4-substituidas intermedias com accao anti-tumoral
DE69813231T2 (de) Natürliche antitumor- oder antivirale substanzen und ihre anwendung
DE3683836D1 (de) Glucopyranose-derivate.
ES2037401T3 (es) Procedimiento para preparar derivados de nucleosidos.
ATE216393T1 (de) Salze von glukopyranosederivate und ihre zwischenprodukte
ES2164013A1 (es) Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.